SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-037913
Filing Date
2024-08-20
Accepted
2024-08-20 16:01:49
Documents
4
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20022160x2_def14a.htm DEF 14A 603431
2 ny20022160x1_pc01.jpg GRAPHIC 790975
3 ny20022160x1_pc02.jpg GRAPHIC 729845
4 sig_rajmehra.jpg GRAPHIC 14562
  Complete submission text file 0001140361-24-037913.txt   2718469
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22245 | Film No.: 241225038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)